ANS Drugs: α1-Adrenergic Antagonists and Vasopressor Interactions in Critical Care

A 55-year-old man with sepsis secondary to pneumonia caused by Pseudomonas aeruginosa is on mechanical ventilation in the ICU. He is currently receiving piperacillin-tazobactam and requires vasopressor support. His blood pressure is 88/52 mmHg despite adequate fluid resuscitation. The intensivist plans to add noradrenaline infusion. However, the patient also has a history of benign prostatic hyperplasia (BPH) for which he was taking tamsulosin at home. Which of the following best explains the pharmacological concern when combining noradrenaline with prior tamsulosin exposure in this clinical scenario?